| Cue Biopharma, Inc. (CUE) | 2.06% | $72.85M | 92.33% | 67.42% | 5.24 |
| Gain Therapeutics, Inc. (GANX) | 1.69% | $68.95M | N/A | N/A | N/A |
| AVROBIO, Inc. (AVRO) | 1.67% | $551.06M | N/A | N/A | N/A |
| Nascent Biotech, Inc. (NBIO) | 1.33% | $12.05M | N/A | N/A | N/A |
| CorMedix, Inc. (CRMD) | 1.33% | $635.95M | N/A | 36.75% | 253.66 |
| MeiraGTx Holdings Plc (MGTX) | 1.31% | $475.23M | -92.03% | -1,042.55% | 31.84 |
| Kezar Life Sciences, Inc. (KZR) | 1.29% | $60.11M | N/A | N/A | -14.69 |
| Kodiak Sciences, Inc. (KOD) | 1.23% | $190.47M | N/A | N/A | N/A |
| Neoleukin Therapeutics, Inc. (NLTX) | 1.19% | $706.61M | N/A | 11.68% | 515.01 |
| Renovaro, Inc. (ENOB) | 1.17% | $106.21M | N/A | N/A | N/A |
| Voyager Therapeutics, Inc. (VYGR) | 1.15% | $440.08M | 509.48% | 95.29% | 0.92 |
| Graphite Bio, Inc. (GRPH) | 1.12% | $723.42M | N/A | N/A | N/A |
| Reneo Pharmaceuticals, Inc. (RPHM) | 1.10% | $61.86M | N/A | N/A | N/A |
| Vigil Neuroscience, Inc. (VIGL) | 1.09% | $157.00M | N/A | N/A | N/A |
| uniQure NV (QURE) | 1.07% | $312.64M | 359.37% | 8.94% | 8.22 |
| Spruce Biosciences, Inc. (SPRB) | 1.05% | $21.44M | -25.64% | 99.25% | -4.67 |
| Coeptis Therapeutics Holdings, Inc. (BHSE) | 1.04% | $8.37M | N/A | N/A | N/A |
| Rani Therapeutics Holdings, Inc. (RANI) | 1.02% | $86.54M | N/A | N/A | N/A |
| BioAtla, Inc. (BCAB) | 1.01% | $93.77M | N/A | N/A | N/A |
| Seer, Inc. (California) (SEER) | 1.00% | $110.75M | -23.35% | 7.45% | -10.21 |
| XBiotech, Inc. (XBIT) | 0.99% | $230.00M | N/A | N/A | N/A |
| Ventyx Biosciences, Inc. (VTYX) | 0.99% | $179.50M | N/A | N/A | N/A |
| Athira Pharma, Inc. (ATHA) | 0.98% | $18.16M | N/A | N/A | N/A |
| Larimar Therapeutics, Inc. (LRMR) | 0.98% | $495.14M | N/A | N/A | N/A |
| IO Biotech, Inc. (IOBT) | 0.98% | $81.69M | N/A | N/A | N/A |
| Aadi Bioscience, Inc. (AADI) | 0.98% | $51.94M | -0.37% | 87.41% | -1.36 |
| Akoya Biosciences, Inc. (AKYA) | 0.97% | $155.43M | -1.52% | 57.79% | 1.66 |
| Cyclo Therapeutics, Inc. (CYTH) | 0.97% | $22.21M | 5.11% | -656.37% | 33.77 |
| Spyre Therapeutics, Inc. (AGLE) | 0.97% | $1.67B | -100.00% | N/A | N/A |
| Aspira Women's Health, Inc. (AWH) | 0.97% | $13.97M | -2.73% | 58.65% | 2.25 |
| Replimune Group, Inc. (REPL) | 0.94% | $787.75M | N/A | N/A | N/A |
| Xeris Biopharma Holdings, Inc. (XERS) | 0.93% | $455.94M | 26.46% | 78.15% | 2.90 |
| LAVA Therapeutics NV (LVTX) | 0.92% | $44.17M | -100.00% | N/A | -4.37 |
| Verastem, Inc. (VSTM) | 0.92% | $119.12M | N/A | 99.94% | 5.97 |
| InflaRx NV (IFRX) | 0.92% | $93.62M | N/A | -5,376.69% | 202.13 |
| ImmuCell Corp. (ICCC) | 0.92% | $28.90M | 54.92% | 22.48% | 2.26 |
| AlloVir, Inc. (ALVR) | 0.90% | $87.67M | N/A | N/A | N/A |
| Enlivex Therapeutics Ltd. (ENLV) | 0.90% | $32.54M | N/A | N/A | N/A |
| Syros Pharmaceuticals, Inc. (SYRS) | 0.90% | $52.55M | -100.00% | N/A | 44.44 |
| Ikena Oncology, Inc. (IKNA) | 0.89% | $82.52M | -100.00% | N/A | -30.75 |
| C4 Therapeutics, Inc. (CCCC) | 0.89% | $440.29M | 350.68% | 82.97% | 4.16 |
| Carisma Therapeutics, Inc. (SESN) | 0.89% | $40.50M | 158.34% | 97.23% | 1.28 |
| Co-Diagnostics, Inc. (CODX) | 0.89% | $40.85M | -18.56% | -241.70% | -0.72 |
| Vaxart, Inc. (VXRT) | 0.88% | $186.43M | 371.35% | 82.82% | 6.02 |
| BioXcel Therapeutics, Inc. (BTAI) | 0.88% | $23.05M | 141.58% | 87.41% | 41.15 |
| INmune Bio, Inc. (INMB) | 0.88% | $113.30M | -100.00% | N/A | 1,701.80 |
| VistaGen Therapeutics, Inc. (VTGN) | 0.87% | $83.06M | -52.70% | -79.76% | 0.13 |
| Enzo Biochem, Inc. (ENZ) | 0.87% | $59.18M | -50.20% | 46.53% | -0.05 |
| TScan Therapeutics, Inc. (TCRX) | 0.87% | $261.50M | -82.97% | -108.21% | 37.45 |
| Mersana Therapeutics, Inc. (MRSN) | 0.87% | $257.62M | -78.48% | 82.42% | 3.86 |
| PepGen Inc. (PEPG) | 0.87% | $291.35M | N/A | N/A | N/A |
| Aldeyra Therapeutics, Inc. (ALDX) | 0.87% | $338.70M | N/A | N/A | N/A |
| Humacyte, Inc. (HUMA) | 0.86% | $629.80M | N/A | N/A | N/A |
| Leap Therapeutics, Inc. (LPTX) | 0.86% | $102.36M | N/A | N/A | N/A |
| Galectin Therapeutics, Inc. (GALT) | 0.86% | $166.28M | N/A | N/A | N/A |
| Spero Therapeutics, Inc. (SPRO) | 0.86% | $69.18M | 663.58% | 99.97% | 0.11 |
| Affimed NV (AFMD) | 0.86% | $54.06M | -89.04% | N/A | 21.30 |
| Sangamo Therapeutics, Inc. (SGMO) | 0.86% | $191.71M | -94.79% | -622.75% | 6.06 |
| Taysha Gene Therapies, Inc. (TSHA) | 0.86% | $422.18M | -53.57% | 73.02% | 31.54 |
| Precigen, Inc. (PGEN) | 0.86% | $274.22M | -59.42% | -209.90% | 87.84 |
| Nautilus Biotechnology, Inc. (NAUT) | 0.86% | $369.96M | N/A | N/A | N/A |
| Design Therapeutics, Inc. (DSGN) | 0.85% | $316.79M | N/A | N/A | N/A |
| Stoke Therapeutics, Inc. (STOK) | 0.85% | $684.42M | N/A | 77.02% | 31.48 |
| Century Therapeutics, Inc. (IPSC) | 0.84% | $135.55M | 678.79% | -349.03% | 33.94 |
| OncoCyte Corp. (OCX) | 0.84% | $52.69M | -77.54% | -221.63% | 31.65 |
| Compugen Ltd. (CGEN) | 0.84% | $153.11M | N/A | 76.84% | 1.43 |
| Precision BioSciences, Inc. (DTIL) | 0.83% | $64.67M | 152.15% | 97.23% | -0.28 |
| Champions Oncology, Inc. (CSBR) | 0.83% | $60.08M | 11.94% | 49.70% | 1.39 |
| Quince Therapeutics, Inc. (CRTX) | 0.82% | $34.40M | N/A | N/A | N/A |
| Greenwich LifeSciences, Inc. (GLSI) | 0.81% | $177.85M | N/A | N/A | N/A |
| Trevi Therapeutics, Inc. (TRVI) | 0.81% | $226.49M | N/A | N/A | N/A |
| MiNK Therapeutics, Inc. (INKT) | 0.81% | $27.01M | N/A | N/A | N/A |
| Curis, Inc. (CRIS) | 0.80% | $31.63M | 15.89% | 97.09% | 5.29 |
| Elutia, Inc. (AZYO) | 0.80% | $106.49M | -38.90% | 44.49% | 5.58 |
| Nuvation Bio, Inc. (NUVB) | 0.80% | $831.11M | N/A | -10.87% | 297.62 |
| SAB Biotherapeutics, Inc. (SABS) | 0.79% | $27.78M | 207.70% | -288.39% | -1.18 |
| Altimmune, Inc. (ALT) | 0.79% | $488.97M | -16.67% | -1,120.00% | 754.43 |
| Compass Pathways Plc (CMPS) | 0.79% | $437.00M | N/A | N/A | N/A |
| CARA Therapeutics, Inc. (CARA) | 0.78% | $14.54M | -85.71% | 92.23% | 0.42 |
| Avid Bioservices, Inc. (CDMO) | 0.78% | $647.52M | 6.49% | 14.22% | 5.87 |
| HOOKIPA Pharma, Inc. (HOOK) | 0.78% | $39.78M | -51.85% | 44.65% | 0.04 |
| Anixa Biosciences, Inc. (ANIX) | 0.77% | $96.86M | N/A | N/A | N/A |
| Heron Therapeutics, Inc. (HRTX) | 0.76% | $266.94M | 13.42% | 70.80% | 4.73 |
| Cognition Therapeutics, Inc. (CGTX) | 0.76% | $19.84M | N/A | N/A | N/A |
| Monte Rosa Therapeutics, Inc. (GLUE) | 0.76% | $338.78M | N/A | 56.12% | 8.43 |
| BioVie, Inc. (BIVI) | 0.76% | $18.76M | N/A | N/A | N/A |
| Passage Bio, Inc. (PASG) | 0.76% | $35.79M | N/A | N/A | N/A |
| HCW Biologics Inc. (HCWB) | 0.76% | $19.67M | -0.63% | 8.16% | 8.50 |
| Adaptimmune Therapeutics Plc (ADAP) | 0.76% | $215.52M | 2,394.41% | 97.86% | 0.61 |
| Solid Biosciences, Inc. (SLDB) | 0.75% | $254.73M | N/A | N/A | N/A |
| Jasper Therapeutics, Inc. (JSPR) | 0.75% | $302.71M | N/A | N/A | N/A |
| iTeos Therapeutics, Inc. (ITOS) | 0.75% | $344.40M | N/A | 99.12% | 0.67 |
| Fate Therapeutics, Inc. (FATE) | 0.75% | $367.83M | 625.83% | 30.29% | 14.69 |
| Bionano Genomics, Inc. (BNGO) | 0.73% | $28.66M | -10.29% | 33.26% | 1.19 |
| Immunome, Inc. (IMNM) | 0.73% | $737.47M | -44.55% | 71.53% | 41.70 |
| Nkarta, Inc. (NKTX) | 0.73% | $300.58M | N/A | N/A | N/A |
| ImmunoPrecise Antibodies Ltd. (IPA) | 0.72% | $15.07M | -9.84% | 33.25% | 1.70 |
| Invivyd, Inc. (ADGI) | 0.72% | $115.47M | N/A | 73.41% | -7.02 |
| ProKidney Corp. (DNAC) | 0.72% | $248.32M | N/A | N/A | N/A |
| Agenus, Inc. (AGEN) | 0.71% | $99.66M | -7.06% | 85.21% | 4.33 |
| Omega Therapeutics, Inc. (OMGA) | 0.69% | $58.46M | 181.16% | 71.27% | 30.87 |
| Foghorn Therapeutics, Inc. (FHTX) | 0.69% | $424.37M | 23.02% | 88.39% | 1.49 |
| Vor Biopharma, Inc. (VOR) | 0.69% | $47.20M | N/A | N/A | N/A |
| Seres Therapeutics, Inc. (MCRB) | 0.67% | $144.19M | -100.00% | N/A | 671.28 |
| Prelude Therapeutics, Inc. (PRLD) | 0.67% | $80.13M | N/A | N/A | N/A |
| X4 Pharmaceuticals, Inc. (XFOR) | 0.66% | $87.54M | N/A | 17.94% | 46.07 |
| Poseida Therapeutics, Inc. (PSTX) | 0.65% | $237.98M | 29.78% | 94.81% | 1.46 |
| 23andMe Holding Co. (ME) | 0.65% | $86.00M | -33.60% | 36.44% | 0.49 |
| Black Diamond Therapeutics, Inc. (BDTX) | 0.62% | $187.03M | N/A | N/A | N/A |
| Climb Bio, Inc. (ELYM) | 0.53% | $336.64M | N/A | N/A | N/A |
| Instil Bio, Inc. (TIL) | 0.51% | $243.57M | N/A | N/A | N/A |
| Shattuck Labs, Inc. (STTK) | 0.32% | $64.43M | 704.50% | 40.21% | 22.92 |
| Gritstone bio, Inc. (GRTS) | 0.07% | $5.57M | -85.75% | -2,707.02% | 270.26 |
| Vaxxinity, Inc. (VAXX) | 0.04% | $0.25M | N/A | N/A | N/A |
| eFFECTOR Therapeutics, Inc. (EFTR) | 0.02% | $0.01M | N/A | N/A | N/A |